Cedars-Sinai surgeon and policymaker honored for work in liver disease and transplantation

May 01, 2014

LOS ANGELES (May 1, 2014) - Andrew S. Klein MD, MBA, director of the Cedars-Sinai Comprehensive Transplant Center is being honored for a lifetime of achievement in the field of liver transplantation by the Los Angeles chapter of the American Liver Foundation.

"This is a wonderful opportunity to bring attention to someone who has had such a profound impact on patients and their families in our community," said Taly Fantini, executive director of the Greater Los Angeles Division of the American Liver Foundation. "We want to honor Dr. Klein with our 'Healthcare Visionary' award for his pioneering work in the field of liver transplantation and hepotobiliary surgery and for tirelessly promoting awareness and education about liver disease."

As a surgeon and medical researcher, Klein, the Esther and Mark Schulman Chair in Surgery and Transplantation Medicine, has written extensively about liver disease, transplantation and immunobiology and has helped establish rules and guidelines for the nation's transplant system.

"The remarkable thing about Andrew Klein is that his wonderful achievements are not confined to the clinic or the operating room or the laboratory," said Shlomo Melmed, MD, senior vice president and dean at Cedars-Sinai and the Helene A. and Philip E. Hixon Chair in Investigative Medicine. "He has also played a key leadership role in the national transplant arena by spearheading development of national policies for equitable allocation of the precious supply of available donor organs."

Klein is a former chair of the United Network of Organ Sharing (UNOS) Liver and Intestinal Transplantation Committee, as well as a member of the governing board of the American Association for the Study of Liver Diseases.
-end-
The American Liver Foundation is dedicated to the prevention and treatment of liver disease and to education and advocacy for patients. Klein will be honored Sunday, May 4, at the foundation's 8th annual gala in Santa Monica, California.

Cedars-Sinai Medical Center

Related Liver Disease Articles from Brightsurf:

Fatty liver disease despite a normal weight
Researchers from the University of Tsukuba found significant differences in the clinical presentation of non-obese patients with non-alcoholic fatty liver disease (NAFLD) based on their sex and body mass index.

Sobering reminder about liver disease
Alcohol's popularity and its central place in socialising in Australia obscures the dangers of excessive drinking and possible liver disease, Flinders University experts warn.

Giant leap in diagnosing liver disease
A collaborative team of Salk Institute and UC San Diego scientists have created a novel microbiome-based diagnostic tool that, with the accuracy of the best physicians, quickly and inexpensively identifies liver fibrosis and cirrhosis over 90 percent of the time in human patients.

Link between liver and heart disease could lead to new therapeutics
A newly published study of flies found that protecting liver function also preserves heart health.

Fatty liver disease is underdiagnosed in the US
According to an analysis published in Alimentary Pharmacology & Therapeutics, nonalcoholic fatty liver disease (NAFLD) is grossly underdiagnosed in the United States.

Possible new treatment strategy for fatty liver disease
Researchers at Karolinska Institutet in Sweden have identified a molecular pathway that when silenced could restore the normal function of immune cells in people with fatty liver disease.

Longevity protein SIRT6 also protects against fatty liver and fatty liver disease
SIRT6 regulates fat metabolism by activating another protein called peroxisome proliferator-activated receptor alpha (PPAR-alpha).

Fresh insights could lead to new treatments for liver disease
The fight against liver disease could be helped by the discovery of cells that cause liver scarring.

Better methods needed for predicting risk of liver disease
While blood samples can reliably identify people with a low risk of developing severe liver disease, better methods are needed in primary care for identifying people in most need of care.

Lab-on-a-chip may help identify new treatments for liver disease
Investigators have developed a 'lab on a chip' technology that can simulate different levels of non-alcoholic fatty liver disease progression.

Read More: Liver Disease News and Liver Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.